share_log

Merit Medical Systems (NASDAQ:MMSI) Upgraded to Strong-Buy by StockNews.com

Merit Medical Systems (NASDAQ:MMSI) Upgraded to Strong-Buy by StockNews.com

优点医疗系统公司(纳斯达克代码:MMSI)升级为Strong-Buy by StockNews.com
Defense World ·  2023/01/03 03:21

Merit Medical Systems (NASDAQ:MMSI – Get Rating) was upgraded by equities research analysts at StockNews.com from a "buy" rating to a "strong-buy" rating in a research note issued to investors on Tuesday.

在周二发给投资者的一份研究报告中,斯托克新闻网的股票研究分析师将优点医疗系统公司(纳斯达克代码:MMSI-GET评级)的评级从“买入”上调至“强力买入”。

Several other equities research analysts have also recently commented on MMSI. Canaccord Genuity Group boosted their target price on Merit Medical Systems from $69.00 to $73.00 in a report on Monday, November 7th. TheStreet upgraded shares of Merit Medical Systems from a "c+" rating to a "b-" rating in a research report on Friday, September 16th. Raymond James lifted their price target on shares of Merit Medical Systems from $71.00 to $72.00 and gave the stock an "outperform" rating in a research report on Thursday, October 27th. Canaccord Genuity Group lowered shares of Merit Medical Systems from a "buy" rating to a "hold" rating and decreased their price target for the stock from $73.00 to $72.00 in a research report on Tuesday, December 20th. Finally, Piper Sandler lifted their price objective on shares of Merit Medical Systems from $70.00 to $73.00 in a research report on Thursday, October 27th. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $73.50.

其他几位股票研究分析师最近也对MMSI发表了评论。在11月7日星期一的一份报告中,Canaccel Genuity Group将Merit Medical Systems的目标价从69.00美元上调至73.00美元。华尔街在9月16日星期五的一份研究报告中将Merit Medical Systems的股票评级从“c+”上调至“b-”。雷蒙德·詹姆斯在10月27日(星期四)的一份研究报告中将Merit Medical Systems的股票目标价从71.00美元上调至72.00美元,并给予该股“跑赢大盘”的评级。在12月20日星期二的一份研究报告中,Canaccel Genuity Group将Merit Medical Systems的股票评级从买入下调至持有,并将该股的目标价从73.00美元下调至72.00美元。最后,在10月27日星期四的一份研究报告中,派珀·桑德勒将Merit Medical Systems的股票目标价从70.00美元上调至73.00美元。一位研究分析师对该股的评级为持有,四位分析师发布了买入评级,一位分析师对该公司给予了强烈的买入评级。根据MarketBeat的数据,该公司目前的平均评级为“买入”,共识目标价为73.50美元。

Get
到达
Merit Medical Systems
优点医疗系统
alerts:
警报:

Merit Medical Systems Price Performance

优点医疗系统性价比

Shares of NASDAQ:MMSI opened at $70.62 on Tuesday. Merit Medical Systems has a 12 month low of $50.46 and a 12 month high of $76.14. The stock has a market cap of $4.02 billion, a price-to-earnings ratio of 65.39, a PEG ratio of 2.50 and a beta of 1.01. The stock's 50 day moving average price is $69.92 and its 200 day moving average price is $61.61. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.35 and a quick ratio of 1.19.

纳斯达克:微星周二开盘报70.62美元。优点医疗系统公司的12个月低点为50.46美元,12个月高位为76.14美元。该股市值为40.2亿美元,市盈率为65.39倍,市盈率为2.50倍,贝塔系数为1.01。该股的50日移动均线价格为69.92美元,200日移动均线价格为61.61美元。该公司的债务权益比为0.19,流动比率为2.35,速动比率为1.19。

Merit Medical Systems (NASDAQ:MMSI – Get Rating) last announced its earnings results on Wednesday, October 26th. The medical instruments supplier reported $0.64 EPS for the quarter, topping the consensus estimate of $0.53 by $0.11. Merit Medical Systems had a return on equity of 14.14% and a net margin of 5.43%. The firm had revenue of $287.18 million for the quarter, compared to analysts' expectations of $273.03 million. Equities research analysts anticipate that Merit Medical Systems will post 2.57 earnings per share for the current fiscal year.
优点医疗系统公司(纳斯达克代码:MMSI-GET Rating)最近一次公布财报是在10月26日星期三。这家医疗器械供应商公布本季度每股收益为0.64美元,比普遍预期的0.53美元高出0.11美元。优点医疗系统公司的股本回报率为14.14%,净利润率为5.43%。该公司本季度营收为2.8718亿美元,高于分析师预期的2.7303亿美元。股票研究分析师预计,Merit Medical Systems本财年每股收益将达到2.57美元。

Hedge Funds Weigh In On Merit Medical Systems

对冲基金看好Merit医疗系统

Institutional investors have recently added to or reduced their stakes in the stock. SG Americas Securities LLC boosted its stake in Merit Medical Systems by 746.0% during the second quarter. SG Americas Securities LLC now owns 27,013 shares of the medical instruments supplier's stock worth $1,466,000 after acquiring an additional 23,820 shares in the last quarter. Rhumbline Advisers increased its holdings in Merit Medical Systems by 8.8% during the second quarter. Rhumbline Advisers now owns 143,882 shares of the medical instruments supplier's stock worth $7,808,000 after buying an additional 11,616 shares during the last quarter. Maryland State Retirement & Pension System boosted its position in Merit Medical Systems by 1.4% during the second quarter. Maryland State Retirement & Pension System now owns 20,671 shares of the medical instruments supplier's stock worth $1,122,000 after purchasing an additional 295 shares during the period. Nisa Investment Advisors LLC boosted its position in shares of Merit Medical Systems by 17.5% in the second quarter. Nisa Investment Advisors LLC now owns 4,337 shares of the medical instruments supplier's stock valued at $235,000 after acquiring an additional 647 shares during the period. Finally, M&T Bank Corp lifted its position in Merit Medical Systems by 67.3% during the second quarter. M&T Bank Corp now owns 26,191 shares of the medical instruments supplier's stock valued at $1,422,000 after purchasing an additional 10,535 shares during the last quarter. 95.38% of the stock is currently owned by institutional investors and hedge funds.

机构投资者最近增持或减持了该股。第二季度,SG America Securities LLC将其在Merit Medical Systems的持股增加了746.0%。SG America Securities LLC现在拥有这家医疗器械供应商27,013股股票,价值1,466,000美元,上个季度又收购了23,820股。Rhumbline Advisers在第二季度增持了Merit Medical Systems 8.8%的股份。在上个季度又购买了11,616股后,Rhumbline Advisers现在拥有这家医疗器械供应商143,882股股票,价值7,808,000美元。马里兰州退休和养老金系统在第二季度将其在Merit医疗系统的地位提高了1.4%。马里兰州退休和养老金系统现在拥有这家医疗器械供应商的20,671股股票,价值1,122,000美元,在此期间又购买了295股。NISA Investment Advisors LLC在第二季度将其在Merit Medical Systems的股票头寸增加了17.5%。NISA Investment Advisors LLC现在拥有这家医疗器械供应商4337股股票,价值23.5万美元,在此期间又购买了647股。最后,M&T Bank Corp在第二季度将其在Merit Medical Systems的头寸提高了67.3%。M&T银行(M&T Bank Corp)目前持有这家医疗器械供应商26,191股股票,价值1,422,000美元,此前该公司在上一季度又购买了10,535股。95.38%的股票目前由机构投资者和对冲基金持有。

About Merit Medical Systems

关于功德医疗系统公司

(Get Rating)

(获取评级)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

优点医疗系统公司设计、开发、制造和营销用于介入、诊断和治疗程序的一次性医疗产品,主要用于心脏病学、放射学、肿瘤学、危重护理和内窥镜检查。该公司在心血管和内窥镜两个领域开展业务。

Further Reading

进一步阅读

  • Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
  • Ready for a Recession? Here's One Defensive Stock You Can't Miss
  • Should You Store Your Capital in Pure Storage Stock?
  • Is it Time to Back up the Truck on Ford Stock?
  • Analysts Ring In The New Year With These 2 Q3 Winners
  • Walt Disney Stock Looks Marvelous Down
  • 免费获取StockNews.com关于Merit Medical Systems(MMSI)的研究报告
  • 准备好迎接经济衰退了吗?这里有一只你不能错过预期的防御性股票
  • 您是否应该将您的资本存储在纯存储股票中?
  • 现在是时候支持福特股票的卡车了吗?
  • 分析师与这两位第三季度获胜者一起迎接新年
  • 华特迪士尼股票看起来令人惊讶地下跌

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

接受新闻和评级的优点医疗系统每日-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Merit Medical Systems和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发